Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TAK | ZTS | NBIX | ||
| Company | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 13.40 | 180.80 | 146.23 | ||
| High | 13.57 | 182.17 | 148.88 | ||
| Low | 13.40 | 178.78 | 146.00 | ||
| Last | 13.51 | 179.59 | 146.15 | ||
| Change | +0.15 | +1.01 | +0.46 | ||
| % Change | +1.12% | +0.57% | +0.32% | ||
| Volume | 264,482 | 178,148 | 55,527 | ||
| 20-Day Average Volume | 1,706,035 | 2,079,663 | 680,797 | ||
| Previous Close | 13.36 | 178.58 | 145.69 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.21 | 175.91 | 141.76 | ||
| 20-Day Raw Stochastic | 76.41% | 68.87% | 85.82% | ||
| 20-Day Relative Strength | 55.96% | 56.52% | 61.57% | ||
| Weighted Alpha | -10.56 | -3.13 | +41.83 | ||
| Today's Opinion | 32% Sell | 40% Buy | 100% Buy | ||
| Previous Opinion | 56% Sell | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 64% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.97% since 07/15/24 | +0.64% since 07/15/24 | +0.28% since 07/15/24 | ||
| Low | 13.24 on 07/19/24 | 176.17 on 07/19/24 | 143.09 on 07/19/24 | ||
| High | 13.75 on 07/17/24 | 184.84 on 07/17/24 | 150.39 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | +7.30% since 06/21/24 | +4.69% since 06/21/24 | +9.88% since 06/21/24 | ||
| Low | 12.77 on 06/24/24 | 166.45 on 06/26/24 | 132.62 on 06/26/24 | ||
| High | 13.75 on 07/17/24 | 184.84 on 07/17/24 | 150.39 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | +1.20% since 04/22/24 | +23.07% since 04/22/24 | +10.63% since 04/22/24 | ||
| Low | 12.57 on 06/20/24 | 145.18 on 04/23/24 | 129.33 on 06/20/24 | ||
| High | 13.75 on 07/17/24 | 184.84 on 07/17/24 | 150.39 on 07/16/24 | ||
| 6-Month | |||||
| %Chg | -8.59% since 01/22/24 | -6.32% since 01/22/24 | +5.77% since 01/22/24 | ||
| Low | 12.57 on 06/20/24 | 144.80 on 04/22/24 | 128.00 on 02/07/24 | ||
| High | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 150.39 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,282,220 | 81,485,168 | 14,661,805 | ||
| Shares Outstanding, K | 3,164,837 | 456,295 | 100,637 | ||
| Annual Sales | 29,419,960,000 | 8,544,000,000 | 1,887,100,000 | ||
| Annual Net Income | 994,060,000 | 2,344,000,000 | 249,700,000 | ||
| Last Quarter Sales | 6,938,670,000 | 2,190,000,000 | 515,300,000 | ||
| Last Quarter Net Income | -46,010,000 | 599,000,000 | 43,400,000 | ||
| 60-Month Beta | 0.54 | 0.86 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 05/09/24 | 1.38 on 05/02/24 | 0.42 on 05/01/24 | ||
| Latest Earnings Date | 07/31/24 | 08/06/24 | 08/01/24 | ||
| Most Recent Dividend | 0.261 on 09/28/23 | 0.432 on 07/18/24 | N/A | ||
| Next Ex-Dividends Date | 03/27/24 | 07/18/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 8.65 | 33.25 | 39.71 | ||